Status:
RECRUITING
Translation and Validation of Chinese COMPAT-SF
Lead Sponsor:
Changhai Hospital
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to translate, adapt, and test the reliability of a Chinese version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) for people with chronic panc...
Detailed Description
This multicenter observational study aims to translate, culturally adapt, and validate the Chinese version of the Comprehensive Pain Assessment Tool Short Form (COMPAT-SF) for individuals with chronic...
Eligibility Criteria
Inclusion
- 1\. Diagnosed with chronic pancreatitis (CP) according to the Guidelines for the Diagnosis and Treatment of Chronic Pancreatitis in China (2018 edition). Diagnosis can be confirmed by: •Primary diagnostic criteria: (i) Definitive imaging findings, and (ii) Histopathological confirmation. •Secondary diagnostic criteria: (i) Recurrent upper abdominal pain, (ii) Abnormal serum amylase levels, (iii) Pancreatic exocrine insufficiency, (iv) Pancreatic endocrine insufficiency, (v) Pathogenic gene mutations, and (vi) History of heavy alcohol consumption. •Diagnosis is confirmed if at least one primary criterion or two secondary criteria are met.
- 2\. Experience of pancreatic pain in the past 12 months
Exclusion
- Under 18 years of age.
- No pancreatic-related pain.
- Diagnosed with pancreatic cancer or other tumors.
- Presence of communication or reading impairments.
- Refusal to participate in the study.
Key Trial Info
Start Date :
March 10 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
356 Patients enrolled
Trial Details
Trial ID
NCT06917716
Start Date
March 10 2025
End Date
December 31 2026
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changhai Hospital
Shanghai, Shanghai Municipality, China, 200433